Skip to main content

Market Overview

Why Aurinia's Stock Is Trading Lower Today

Share:
Why Aurinia's Stock Is Trading Lower Today

Aurinia Pharmaceuticals (NASDAQ: AUPH) shares are trading lower on Thursday.

In an SEC filing on Wednesday night, the company announced it and Lonza have entered an exclusive agreement for a dedicated Voclosporin Manufacturing Capacity. The Monoplant is estimated to be operational in 2023.

Aurinia Pharmaceuticals shares were trading down 13.22% at $13.16 on Thursday at the time of publication. The stock has a 52-week high of $21.93 and a 52-week low of $9.83.

 

Related Articles (AUPH)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Small Cap

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com